Research Analysts’ upgrades for Thursday, November 30th:

Akari Therapeutics (NASDAQ:AKTX) was upgraded by analysts at ValuEngine from a strong sell rating to a sell rating.

Arrowhead Pharmaceuticals (NASDAQ:ARWR) was upgraded by analysts at ValuEngine from a strong sell rating to a sell rating.

BioScrip (NASDAQ:BIOS) was upgraded by analysts at ValuEngine from a sell rating to a hold rating.

Cooper Tire & Rubber (NYSE:CTB) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.

Elementis (OTCMKTS:ELMTY) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Elementis plc is a specialty chemicals company. Its business comprises of Specialty Products, Chromium and Surfactants. The company’s product consists of BENTONE(R) organoclays, RHEOLATE(R) rheological additives, DAPRO(R) specialty additives, M-P-A(R) anti-settling agents, NALZIN(R) corrosion and rust inhibitors, THIXATROL(R) rheology additives, NUOSPERSE(R) wetting and dispersing agents, TINT-AYD (R)colorants, SLIP-AYD(R) waxes and slip additives, SERDOX(R) polyglycol ethers, SERDOLAMIDE(R) alkanolamides and SERVOXYL(R) phosphate esters. Elementis plc is based in London, United Kingdom. “

Elevate Credit (NYSE:ELVT) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Elevate Credit, Inc. offer online credit solutions to non-prime consumers. The Company offers online installment loans and lines of credits. Its products include credit building, financial wellness programs, credit reporting, free credit monitoring and online financial literacy videos and tools. Elevate Credit, Inc. is based in Forth Worth, United States. “

HCA (NYSE:HCA) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.

Heron Therapeutics (NASDAQ:HRTX) was upgraded by analysts at ValuEngine from a sell rating to a hold rating.

Laboratory Corporation of America (NYSE:LH) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.

La-Z-Boy (NYSE:LZB) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.

Schmitt Industries (NASDAQ:SMIT) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.

Tilly's (NYSE:TLYS) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.

Vishay Precision Group (NYSE:VPG) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.

Receive News & Ratings for Akari Therapeutics PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akari Therapeutics PLC and related companies with MarketBeat.com's FREE daily email newsletter.